title: Recombinant human erythropoietin alpha modulates the effects of radiotherapy on colorectal cancer microvessels.
abstract: Recent data suggest that recombinant human erythropoietin (rhEPO) modulates tumour growth and therapy response. The purpose of the present study was to examine the modulation of radiotherapy (RT) effects on tumour microvessels by rhEPO in a rat colorectal cancer model. Before and after 5 x 5 Gy of RT, dynamic contrast-enhanced -magnetic resonance imaging was performed and endothelial permeability surface product (PS), plasma flow (F), and blood volume (V) were modelled. Imaging was combined with pO(2) measurements, analysis of microvessel density, microvessel diameter, microvessel fractal dimension, and expression of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1 alpha (HIF-1alpha), Bax, and Bcl-2. We found that RT significantly reduced PS and V in control rats, but not in rhEPO-treated rats, whereas F was unaffected by RT. Oxygenation was significantly better in rhEPO-treated animals, and RT induced a heterogeneous reoxygenation in both groups. Microvessel diameter was significantly larger in rhEPO animals, whereas VEGF expression was significantly lower in the rhEPO group. No differences were observed in HIF-1alpha, Bax, or Bcl-2 expression. We conclude that rhEPO results in spatially heterogeneous modulation of RT effects on tumour microvessels. Direct effects of rhEPO on neoplastic endothelium are likely to explain these findings in addition to indirect effects induced by increased oxygenation.
authors.affiliation: Department of Surgery, Ghent University Hospital, Ghent, Belgium. wim.ceelen@ugent.be
authors.forename: W
authors.initials: W
authors.lastname: Ceelen
authors.forename: T
authors.initials: T
authors.lastname: Boterberg
authors.forename: P
authors.initials: P
authors.lastname: Smeets
authors.forename: N
authors.initials: N
authors.lastname: Van Damme
authors.forename: P
authors.initials: P
authors.lastname: Demetter
authors.forename: O
authors.initials: O
authors.lastname: Zwaenepoel
authors.forename: L
authors.initials: L
authors.lastname: Cesteleyn
authors.forename: P
authors.initials: P
authors.lastname: Houtmeyers
authors.forename: M
authors.initials: M
authors.lastname: Peeters
authors.forename: P
authors.initials: P
authors.lastname: Pattyn
mesh_terms: D000230:Adenocarcinoma / Q000098:blood supply / Q000188:drug therapy* / Q000532:radiotherapy; D000818:Animals; D015179:Colorectal Neoplasms / Q000098:blood supply / Q000188:drug therapy* / Q000532:radiotherapy; D004921:Erythropoietin / Q000494:pharmacology*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008954:Models, Biological; D009389:Neovascularization, Pathologic / Q000188:drug therapy* / Q000532:radiotherapy*; D051381:Rats; D017467:Receptors, Erythropoietin / Q000378:metabolism; D011994:Recombinant Proteins
chemical_list: D017467:Receptors, Erythropoietin; D011994:Recombinant Proteins; D004921:Erythropoietin